Functional Imaging in the Acute Phase of Transient Ischemic Attacks

NCT ID: NCT03928977

Last Updated: 2019-11-19

Study Results

Results pending

The study team has not published outcome measurements, participant flow, or safety data for this trial yet. Check back later for updates.

Basic Information

Get a concise snapshot of the trial, including recruitment status, study phase, enrollment targets, and key timeline milestones.

Recruitment Status

UNKNOWN

Clinical Phase

NA

Total Enrollment

70 participants

Study Classification

INTERVENTIONAL

Study Start Date

2019-10-15

Study Completion Date

2021-02-28

Brief Summary

Review the sponsor-provided synopsis that highlights what the study is about and why it is being conducted.

The aim of the study is to find a radiological biomarker of Transient Ischemic Attacks (TIA) thanks to functional Magnetic Resonance Imaging (fMRI) done within the 24 hour after symptoms onset.

Detailed Description

Dive into the extended narrative that explains the scientific background, objectives, and procedures in greater depth.

Conditions

See the medical conditions and disease areas that this research is targeting or investigating.

Transient Ischemic Attack

Study Design

Understand how the trial is structured, including allocation methods, masking strategies, primary purpose, and other design elements.

Allocation Method

NON_RANDOMIZED

Intervention Model

PARALLEL

Primary Study Purpose

DIAGNOSTIC

Blinding Strategy

SINGLE

Outcome Assessors

Study Groups

Review each arm or cohort in the study, along with the interventions and objectives associated with them.

Confirmed TIA

Confirmed TIA at 3 months with standardized neurological expertise

Group Type OTHER

Functional Magnetic Resonance Imaging

Intervention Type DIAGNOSTIC_TEST

fMRI sequences done with motor paradigm (right and left arm), followed by resting state acquisition

Confirmed non-TIA

Not-confirmed TIA at 3 months with standardized neurological expertise

Group Type OTHER

Functional Magnetic Resonance Imaging

Intervention Type DIAGNOSTIC_TEST

fMRI sequences done with motor paradigm (right and left arm), followed by resting state acquisition

Interventions

Learn about the drugs, procedures, or behavioral strategies being tested and how they are applied within this trial.

Functional Magnetic Resonance Imaging

fMRI sequences done with motor paradigm (right and left arm), followed by resting state acquisition

Intervention Type DIAGNOSTIC_TEST

Eligibility Criteria

Check the participation requirements, including inclusion and exclusion rules, age limits, and whether healthy volunteers are accepted.

Inclusion Criteria

* Patient admitted in for a transient neurologic deficit and suspicion of TIA of carotid circulation
* Prescription for conventionnal MRI

Exclusion Criteria

* Contraindication to MRI
* Previous neurological disease (with lesions)
* Severe psychiatric disease
Minimum Eligible Age

18 Years

Eligible Sex

ALL

Accepts Healthy Volunteers

No

Sponsors

Meet the organizations funding or collaborating on the study and learn about their roles.

Centre Hospitalier Universitaire de Besancon

OTHER

Sponsor Role lead

Responsible Party

Identify the individual or organization who holds primary responsibility for the study information submitted to regulators.

Responsibility Role SPONSOR

Locations

Explore where the study is taking place and check the recruitment status at each participating site.

CHU de Besançon

Besançon, , France

Site Status RECRUITING

Countries

Review the countries where the study has at least one active or historical site.

France

Central Contacts

Reach out to these primary contacts for questions about participation or study logistics.

Louise BONNET, MD

Role: CONTACT

033381668984

Guillaume CHARBONNIER, MD

Role: CONTACT

Facility Contacts

Find local site contact details for specific facilities participating in the trial.

Guillaume Charbonnier, MD

Role: primary

Other Identifiers

Review additional registry numbers or institutional identifiers associated with this trial.

P/2018/370

Identifier Type: -

Identifier Source: org_study_id

More Related Trials

Additional clinical trials that may be relevant based on similarity analysis.